RT Book, Section
A1 Boyd, Leslie
A1 Muggia, Franco
A2 Boyiadzis, Michael M.
A2 Fojo, Tito
SR Print(0)
ID 1187885584
T1 Vaginal Cancer
T2 Hematology-Oncology Therapy, 3e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260117400
LK hemonc.mhmedical.com/content.aspx?aid=1187885584
RD 2024/04/20
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence:6230  (Estimated  new  cases  for  2020  in  the  United  States)Incidence  of  clear  cell  adenocarcinoma  as  a  result  of  in  utero  diethylstilbestrol(DES)  exposure  estimated  at  1/1000Stage  at  presentationLocalized33.1%Regional35.5%Deaths:Estimated  1450  in  2020Distant17.1%Median  age:Squamous  cell  cancer  (60–65  years);  DES-related  adenocarcinoma/clear  cell  (19  years)Unstaged14.3%Daling  JR  et  al.  Gynecol  Oncol  2002;84:263–270Siegel  R  et  al.  CA  Cancer  J  Clin  2020;70:7–30Surveillance,  Epidemiology  and  End  Results  (SEER)  Program,  available  from  http://seer.cancer.gov  [accessed  in  2020]Tedeschi  C  et  al.  J  Low  Genit  Tract  Dis  2005;9:11–18